The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain.
Recruiting
Early Phase 1
Interventional Study
Opioid-Refractory Chronic Cancer-Related Pain
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 24 (estimated)
- Sponsor
- National and Kapodistrian University of Athens · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a randomized, double-blinded, placebo-controlled, cross-over trial examining the effect of a series of two weekly intravenous infusions of lidocaine 4 mg/kg and ketamine 0.2 mg/kg in patients with moderate to severe opioid-refractory chronic cancer-related pain. The aim of this study is to investigate whether the lidocaine - ketamine (LK) regimen provides better analgesia that an active pl…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18 years or more
* Capacity to provide informed consent, ability to complete study assessments and comply with the study procedures
* Meets the IASP definition for chronic cancer-related pain
* Moderate or severe pain, defined as average pain of 4 or greater on an 11-point…
Contacts
Konstantinos Kalimeris MD, PhD, Associate Professor of Anesthesiology, Associate Professor
+302105831997
CONTACT